I am/have/had
I am looking for
Advanced Filters
Found 1345 clinical trials
Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis
Randomized, double-blind, placebo-controlled Phase IIa clinical study, assessing safety, tolerability, pharmacodynamic effects and pharmacokinetics of temelimab, administered at three different dose levels (18 mg/kg or 36 mg/kg or 54 mg/kg). In this study temelimab is administered subsequently to rituximab therapy, i.e. no co-administration of rituximab and temelimab is done in …
rituximab
acquired immunodeficiency syndrome (aids)
multiple sclerosis
- 0 views
- 16 Feb, 2024
- 1 location